News and Events
Velesco has been awarded a subcontract for analytical method development, manufacturing clinical supplies,
and testing the stability of an investigational drug for the treatment for Beta-Thalassemia
through the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS)
through its Therapeutics for Rare and Neglected Diseases (TRND) program! Read the press release here.
Velesco's work published in
a Drug Development & Delivery article!
Read it here.
Dave Barnes Featured in